7 May 2021
NZX/ASX Code: EBO
Senior Management Changes
EBOS Group Limited (“EBOS” or the “Group”) advises of two changes to its Leadership Team.
EBOS is pleased to announce its current Acting Chief Financial Officer (CFO) Leonard Hansen has been permanently appointed to the role of CFO. Leonard has extensive knowledge of all financial aspects of the business having filled a number of senior finance roles across EBOS over the last nine years.
John Cullity, EBOS Chief Executive Officer said, “Leonard has a wealth of experience across EBOS’ diverse portfolio of businesses and I am very pleased he has agreed to take on the role permanently. He is highly capable, well-regarded by his peers and colleagues and I could think of no better qualified person to be in this role”.
EBOS also announced today the resignation of the Chief Executive Officer of its Animal Care and Consumer Brands businesses, Sean Duggan. Sean joined EBOS in 2011 as part of EBOS’ acquisition of Masterpet, where he was CEO at the time. In acknowledging Sean’s service, John Cullity said, “Sean has been instrumental in the growth of EBOS’ Animal Care segment which includes leading brands Blackhawk and Vitapet, our veterinary wholesale business Lyppard and the investment in pet care retailer Animates. On behalf of EBOS I wish to thank Sean for his contribution and the value that he has created and we wish him all the best for the future.”
For further information please contact:
John Cullity
Chief Executive Officer
+61 9918 5555
Authorised for lodgement with NZX and ASX by Janelle Cain, General Counsel, EBOS Group Limited.
About EBOS Group
EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer and distributor.
The company faced the greatest challenges in the sector.
Investors may not be showing NZ firms love, but private equity will.
Bid from Australian private equity firm values shares at between $1.50 and $1.70.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details